The below information on Mylotarg has been taken from official FDA sources, but we cannot guarantee it's accuracy. Please use this site for educational purposes only. This site does not replace a proper discussion with your doctor.
|This drug was approved by the FDA in one form or another on:|
|This drug is made in one form or another by the following companies:|
|This drug is available in the following forms:|
|View the actual FDA approved label for this drug at the following links:|
Mylotarg is used to treat a form of bone marrow cancer (CD33 positive acute myeloid leukemia) in patients who are:
- experiencing a return of the disease after the first treatment
- 60 years of age or older, and
- not considered able to take standard leukemia chemotherapy.
The safety and effectiveness of Mylotarg in patients with poor performance status and organ dysfunction is not known and has not been tested. In addition, the effectiveness of Mylotarg in improving symptoms, keeping the disease from getting worse, or helping patients live longer compared with standard treatments is not known.
Side Effects of Mylotarg
Common side effects include:
- decrease in bone marrow production (see Special Warnings)
- low red blood cell counts (anemia)
- low blood platelets
- swelling of the membrane inside the mouth
- liver problems
If the following side effects occur, they will be soon after treatment with Mylotarg. Other medicines can be prescribed to improve these conditions:
- changes in blood pressure
- low levels of oxygen in the body
Who Should Not Take Mylotarg
When large numbers of leukemic cancer cells are being destroyed quickly, you may experience side effects which may cause pain in the joints (gout) or even kidney problems.
Recent Forum Posts on Mylotarg
Site Copyright © 2003-2008 Jalic Inc. All rights reserved.